Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blossomhill Therapeutics IncfiledCriticalBlossomhill Therapeutics Inc
Publication of AR129569A1publicationCriticalpatent/AR129569A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un compuesto de la fórmula (1). Una composición farmacéutica que comprende un compuesto de cualquiera de las reivindicaciones anteriores y, opcionalmente, uno o más excipientes.A compound of formula (1). A pharmaceutical composition comprising a compound of any of the preceding claims and, optionally, one or more excipients.
ARP230101471A2020-05-092023-06-08
INDAZOLE MACROCYCLES AND THEIR USE
AR129569A1
(en)
Compounds derived from 2,4-diaminoquinazoline; pharmaceutical composition; and its use for the treatment of a viral infection, cancer, among others (divisional application 202002253).
USE OF A COMBINATION OF A QUINASA P38 INHIBITING DERIVED COMPOUND OF PIRAZOL, AND AN ACE INHIBITOR TO TREAT RENAL DYSFUNCTION, CARDIOVASCULAR AND VASCULAR DISEASE, RETINOPATHY, NEUROPATIA, EDOTEL, INSOTUNATIO OPINION.